Progenitor skin cell therapy and evolution of medical applications
Alternatives for Dermal Toxicity Testing, Page: 547-564
2017
- 1Citations
- 1Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Book Chapter Description
Organs and cells can be efficiently used and transformed into intermediate or final products that propose many advances in new medical technology from skin grafting to 3D micro-tissues for biocompatibility and industry testing. For instance, cell sources that can be easily expanded and stocked from allogeneic sources would be interesting in order to avoid the biopsy from the patient and the time necessary to prepare the cells before treatments of patients. Also, cell sources used historically in medicine can provide enough banked cells not only designated for treatment of patients but also for developing innovative testing platforms with uniform primary cell populations.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85042606669&origin=inward; http://dx.doi.org/10.1007/978-3-319-50353-0_40; http://link.springer.com/10.1007/978-3-319-50353-0_40; http://link.springer.com/content/pdf/10.1007/978-3-319-50353-0_40; https://dx.doi.org/10.1007/978-3-319-50353-0_40; https://link.springer.com/chapter/10.1007%2F978-3-319-50353-0_40
Springer Nature
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know